Nextremity Solutions Announces Upcoming Commercial Launch of LapiPrep®, a New Lapidus Correction and Preparation System

New instrumentation designed for accurate and repeatable deformity correction


Nextremity Solutions, Inc., a Strategic Commercialization Organization (SCO) with a focus on the extremity musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., announces the upcoming commercial launch of its new LapiPrep System this Spring.

The LapiPrep System is an instrument system that provides surgeons with a comprehensive, versatile jig and integrated, modular components that is designed to allow for accurate and repeatable deformity correction and precise preparation of the first metatarsal and medial cuneiform of a patient’s foot to perform a Lapidus bunion procedure. Precisely controlling the IM angle, frontal plane rotation, and sagittal plane correction of the metatarsal, all while allowing surgeons the ability to distract and compress as needed is the hallmark of the system. The patent pending design and modularity allows for curettage, saw cuts, or burr preparation as determined by the surgeon and their specific surgical preference, whether traditional open or MIS.

The system was purposefully designed to guide and facilitate, but allow surgeons a choice in preparation technique as well as final determination of the fixation method that is best for the patient; namely crossing screws, plating options, etc.

“The goal of LapiPrep was to design a simple and straightforward system to address and assist the surgeon with the challenging aspects of the Lapidus procedure, while providing flexibility and freedom to the surgeon. The engineers and surgeon team have spent an extraordinary amount of time to get this right, and we’re excited to introduce it to the market,” stated Ryan D. Schlotterback, Chief Technology Officer for Nextremity Solutions.

To keep up to date with the status of the commercial launch of the LapiPrep Lapidus Correction and Preparation System, Nextremity has developed a web page at http://www.LapiPrep.com where interested parties can subscribe for future announcements and progress updates.

LapiPrep is a trademark of Nextremity Solutions, Inc. LapiPrep is not currently available for sale.

Patent Pending

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held Strategic Commercialization Organization (SCO) with a focus on lower and upper extremity, trauma, sports medicine and joint preservation, offering innovative solutions and Revenue Ready® products for various extremity musculoskeletal applications and for the benefit of our industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button